title: Clinical relevance of cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
authors.affiliation: aDivision of Infectious Diseases, Department of Internal Medicine, Taipei City Hospital, Kun-Ming Branch bDepartment of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei cDepartment of Medical Research, China Medical University Hospital dChina Medical University, Taichung, Taiwan.
authors.forename: Kuan-Yin
authors.initials: KY
authors.lastname: Lin
authors.forename: Chien-Ching
authors.initials: CC
authors.lastname: Hung
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D000069454:Darunavir / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000453:epidemiology / Q000473:pathology; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D012189:Retrospective Studies; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000069454:Darunavir